PDCD1 and neoplasm: Hence, following reduction of the bulk tumour by conventional chemotherapy, blocking the PDCD1 inhibitory pathway might release a ‘brake’ on the T cell receptor signalling and reasonably increase tumour-specific cytotoxicity.